Sensyne Health plc announced earnings results for the half year ended October 31, 2020. For the half year, the company announced sales was GBP 2.318 million compared to GBP 392,000 a year ago. Operating loss was GBP 13.589 million compared to GBP 9.837 million a year ago. Net loss was GBP 13.809 million compared to GBP 9.894 million a year ago. Basic loss per share from continuing operations was GBP 0.11 compared to GBP 0.08 a year ago.